Completed NA INTERVENTIONAL 2-arm NCT01302470

Comparison of Epicardial Versus Conventional Lead Placement in Cardiac Resynchronization Therapy (REVERT)

Randomized Study of Endovascular Versus Epicardial Lead Placement for Resynchronization Therapy

Sponsor: Montefiore Medical Center

Conditions Cardiac Resynchronization Therapy Heart Failure

Interventions Primary epicardial placement of left ventricular lead Transvenous placement of left ventricular lead

Updated 6 times since 2017 Last updated: Feb 18, 2015 Started: Feb 28, 2005 Primary completion: Mar 31, 2012 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01302470, this NA trial focuses on Cardiac Resynchronization Therapy and Heart Failure and remains completed. Sponsored by Montefiore Medical Center, it has been updated 6 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Montefiore Medical Center
St. Luke's-Roosevelt Hospital Center

Data source: St. Luke's-Roosevelt Hospital Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States